Skip to content
Member Login
Meeting

Virtual Roundtable: What a World Without Chevron Means for U.S. Health

Event date


Speaker

  • Nicholas Bagley
    Thomas G. Long Professor of Law, University of Michigan Law School

Presider

  • Thomas J. Bollyky
    Bloomberg Chair in Global Health; Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council on Foreign Relations

From Global Health Economics And Development Roundtable Series, Global Health Program, and Renewing America.

In January, the U.S. Supreme Court debated whether to overturn Chevron v. Natural Resources Defense Council—one of the most cited U.S. cases of all time, which established the principle that the courts should defer to federal agencies when they interpret the law in the course of carrying out their duties. During the COVID-19 pandemic, the deference owed to federal agencies’ exercise of public health authorities was already heavily litigated. How much overruling Chevron would alter U.S. health policymaking is a matter of debate, with some claiming the change would be modest while others argue that FDA decision-making and Medicare administration would be rendered unworkable.

Mr. Nicholas Bagley, the Thomas G. Long Professor of Law at Michigan Law and an expert on administrative law and health law, and Thomas J. Bollyky discuss what replacing the Chevron doctrine might mean for U.S. health.